Vera Therapeutics IncNASDAQ:VERA
- LAST PRICE40.8400
- TODAY'S CHANGE (%)0.3500 (0.8644%)
- Bid / Lots41.0100/ 1
- Ask / Lots43.3200/ 1
- Open / Previous Close40.9300 / 40.4900
- Day Range
- 52 Week Range
- Volume456,880
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VERA |
|---|---|---|
| 09:32 ET | 2162 | 41.36 |
| 09:38 ET | 100 | 41.06 |
| 09:41 ET | 53980 | 41.39 |
| 09:45 ET | 500 | 41.4 |
| 09:48 ET | 132 | 41.4 |
| 09:52 ET | 700 | 41.41 |
| 09:54 ET | 100 | 41.365 |
| 09:56 ET | 500 | 41.0901 |
| 09:57 ET | 535 | 41.12 |
| 09:59 ET | 200 | 41.07 |
| 10:01 ET | 874 | 41.03 |
| 10:06 ET | 102 | 40.94 |
| 10:08 ET | 200 | 41.06 |
| 10:10 ET | 245 | 41.09 |
| 10:14 ET | 100 | 41 |
| 10:15 ET | 300 | 41.03 |
| 10:17 ET | 300 | 41.035 |
| 10:19 ET | 4772 | 40.84 |
| 10:24 ET | 100 | 40.76 |
| 10:28 ET | 100 | 40.705 |
| 10:30 ET | 4300 | 40.555 |
| 10:32 ET | 200 | 40.435 |
| 10:33 ET | 400 | 40.5 |
| 10:35 ET | 323 | 40.515 |
| 10:37 ET | 300 | 40.545 |
| 10:39 ET | 211 | 40.46 |
| 10:42 ET | 3586 | 40.475 |
| 10:44 ET | 700 | 40.44 |
| 10:46 ET | 100 | 40.545 |
| 10:48 ET | 500 | 40.48 |
| 10:50 ET | 838 | 40.315 |
| 10:55 ET | 1308 | 40.41 |
| 10:57 ET | 1100 | 40.5 |
| 11:00 ET | 1400 | 40.515 |
| 11:02 ET | 300 | 40.53 |
| 11:06 ET | 400 | 40.47 |
| 11:08 ET | 100 | 40.42 |
| 11:09 ET | 100 | 40.54 |
| 11:11 ET | 500 | 40.4975 |
| 11:13 ET | 900 | 40.41 |
| 11:15 ET | 1976 | 40.49 |
| 11:20 ET | 300 | 40.455 |
| 11:22 ET | 1917 | 40.38 |
| 11:24 ET | 1585 | 40.4 |
| 11:26 ET | 500 | 40.41 |
| 11:27 ET | 100 | 40.4 |
| 11:29 ET | 306 | 40.405 |
| 11:31 ET | 958 | 40.395 |
| 11:33 ET | 300 | 40.36 |
| 11:36 ET | 100 | 40.395 |
| 11:38 ET | 4946 | 40.47 |
| 11:40 ET | 1695 | 40.355 |
| 11:42 ET | 1410 | 40.31 |
| 11:44 ET | 200 | 40.325 |
| 11:45 ET | 500 | 40.325 |
| 11:47 ET | 400 | 40.315 |
| 11:49 ET | 500 | 40.345 |
| 11:51 ET | 1600 | 40.38 |
| 11:54 ET | 857 | 40.345 |
| 11:56 ET | 928 | 40.345 |
| 11:58 ET | 702 | 40.3 |
| 12:00 ET | 600 | 40.34 |
| 12:02 ET | 2029 | 40.24 |
| 12:03 ET | 2607 | 40.22 |
| 12:05 ET | 1900 | 40.3 |
| 12:07 ET | 1025 | 40.3 |
| 12:09 ET | 1000 | 40.245 |
| 12:12 ET | 400 | 40.225 |
| 12:14 ET | 4124 | 40.38 |
| 12:16 ET | 524 | 40.325 |
| 12:18 ET | 100 | 40.39 |
| 12:20 ET | 1000 | 40.32 |
| 12:21 ET | 300 | 40.38 |
| 12:23 ET | 626 | 40.38 |
| 12:25 ET | 200 | 40.33 |
| 12:27 ET | 900 | 40.33 |
| 12:30 ET | 6398 | 40.23 |
| 12:32 ET | 2679 | 40.01 |
| 12:34 ET | 724 | 39.97 |
| 12:36 ET | 2700 | 40.09 |
| 12:38 ET | 2501 | 40.1 |
| 12:39 ET | 500 | 40.19 |
| 12:41 ET | 8650 | 40.43 |
| 12:43 ET | 200 | 40.37 |
| 12:45 ET | 200 | 40.38 |
| 12:48 ET | 100 | 40.44 |
| 12:50 ET | 936 | 40.37 |
| 12:52 ET | 6829 | 40.26 |
| 12:54 ET | 1529 | 40.27 |
| 12:56 ET | 700 | 40.315 |
| 12:57 ET | 300 | 40.315 |
| 12:59 ET | 2954 | 40.36 |
| 01:01 ET | 2337 | 40.42 |
| 01:03 ET | 100 | 40.28 |
| 01:06 ET | 300 | 40.28 |
| 01:08 ET | 300 | 40.25 |
| 01:10 ET | 800 | 40.25 |
| 01:12 ET | 100 | 40.22 |
| 01:14 ET | 2222 | 40.38 |
| 01:15 ET | 500 | 40.42 |
| 01:17 ET | 700 | 40.475 |
| 01:19 ET | 724 | 40.545 |
| 01:24 ET | 100 | 40.44 |
| 01:26 ET | 300 | 40.44 |
| 01:28 ET | 300 | 40.38 |
| 01:30 ET | 2600 | 40.53 |
| 01:32 ET | 700 | 40.55 |
| 01:33 ET | 500 | 40.61 |
| 01:35 ET | 300 | 40.53 |
| 01:39 ET | 500 | 40.47 |
| 01:42 ET | 100 | 40.51 |
| 01:44 ET | 1000 | 40.64 |
| 01:46 ET | 1200 | 40.64 |
| 01:48 ET | 1458 | 40.675 |
| 01:51 ET | 613 | 40.625 |
| 01:53 ET | 200 | 40.5 |
| 01:55 ET | 700 | 40.524 |
| 02:00 ET | 500 | 40.4 |
| 02:02 ET | 1934 | 40.49 |
| 02:08 ET | 230 | 40.49 |
| 02:09 ET | 100 | 40.545 |
| 02:11 ET | 749 | 40.6 |
| 02:13 ET | 100 | 40.49 |
| 02:15 ET | 3412 | 40.64 |
| 02:18 ET | 200 | 40.64 |
| 02:20 ET | 200 | 40.61 |
| 02:22 ET | 200 | 40.61 |
| 02:24 ET | 1324 | 40.655 |
| 02:26 ET | 700 | 40.61 |
| 02:27 ET | 100 | 40.6 |
| 02:29 ET | 2855 | 40.72 |
| 02:31 ET | 500 | 40.73 |
| 02:33 ET | 100 | 40.71 |
| 02:36 ET | 955 | 40.67 |
| 02:38 ET | 2024 | 40.88 |
| 02:40 ET | 522 | 40.93 |
| 02:42 ET | 1325 | 41.01 |
| 02:44 ET | 100 | 41.015 |
| 02:45 ET | 200 | 40.99 |
| 02:47 ET | 2000 | 41.04 |
| 02:49 ET | 100 | 41.04 |
| 02:51 ET | 661 | 41 |
| 02:54 ET | 600 | 41.04 |
| 02:56 ET | 1473 | 40.99 |
| 02:58 ET | 1500 | 41.07 |
| 03:02 ET | 5649 | 41.045 |
| 03:03 ET | 400 | 41 |
| 03:05 ET | 1409 | 40.97 |
| 03:07 ET | 1700 | 41.06 |
| 03:09 ET | 1200 | 41.13 |
| 03:12 ET | 500 | 41.155 |
| 03:14 ET | 1871 | 41.065 |
| 03:16 ET | 3756 | 41.06 |
| 03:18 ET | 600 | 41.1 |
| 03:20 ET | 6665 | 41.155 |
| 03:21 ET | 2057 | 41.19 |
| 03:23 ET | 1400 | 41.145 |
| 03:25 ET | 1100 | 41.035 |
| 03:27 ET | 300 | 40.97 |
| 03:30 ET | 800 | 40.97 |
| 03:32 ET | 700 | 40.95 |
| 03:34 ET | 500 | 40.89 |
| 03:36 ET | 2600 | 40.93 |
| 03:38 ET | 600 | 40.86 |
| 03:39 ET | 3216 | 40.96 |
| 03:41 ET | 700 | 40.89 |
| 03:43 ET | 1008 | 40.82 |
| 03:45 ET | 1410 | 40.78 |
| 03:48 ET | 3928 | 40.81 |
| 03:50 ET | 1398 | 40.845 |
| 03:52 ET | 1700 | 40.86 |
| 03:54 ET | 6977 | 40.81 |
| 03:56 ET | 3146 | 40.77 |
| 03:57 ET | 10649 | 40.8 |
| 03:59 ET | 54634 | 40.84 |
Yesterday
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Friday Oct 04, 2024 by Dow Jones
4:05PM ET on Friday Oct 04, 2024 by Dow Jones
Oct 3, 2024
DJ Vera Therapeutics Price Target Maintained With a $107.00/Share by Cantor Fitzgerald, from 11:09AM ET on Thursday Oct 03, 2024 by Dow Jones
11:09AM ET on Thursday Oct 03, 2024 by Dow Jones
Oct 2, 2024
Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases, from 6:30AM ET on Wednesday Oct 02, 2024 by Dow Jones
6:30AM ET on Wednesday Oct 02, 2024 by Dow JonesVera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024, from 6:30AM ET on Wednesday Oct 02, 2024 by Dow Jones
6:30AM ET on Wednesday Oct 02, 2024 by Dow Jones
Oct 1, 2024
DJ Vera Therapeutics Price Target Maintained With a $107.00/Share by Cantor Fitzgerald, from 8:25AM ET on Tuesday Oct 01, 2024 by Dow Jones
8:25AM ET on Tuesday Oct 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vera Therapeutics Inc | 2.2B | -18.5x | --- |
Keros Therapeutics Inc | 2.3B | -11.9x | --- |
Neumora Therapeutics Inc | 2.4B | -8.9x | --- |
Immunitybio Inc | 2.4B | -3.7x | --- |
Janux Therapeutics Inc | 2.3B | -49.2x | --- |
CG Oncology Inc | 2.5B | -31.4x | --- |
Company Information
Vera Therapeutics, Inc. is a late-stage biotechnology company. The Company is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its product candidate, atacicept, is a self-administered fusion protein that blocks both a B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. The Company is also engaged in developing MAU868, a monoclonal antibody designed to neutralize infection with BK Virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplants. The Company is conducting a randomized, double-blind, placebo-controlled Phase 3 clinical trial in IgAN, which it refers to as ORIGIN 3, and completing the open label extension of its Phase 2b clinical trial in IgAN, which it refers to as ORIGIN 2b.
Contact Information
- Headquarters
- 8000 Marina Boulevard,, Suite 120BRISBANE, CA, United States 94005
- Phone
- 650-770-0077
- Fax
- 302-655-5049
Executives
- Independent Non-Executive Chairman of the Board
- Michael Morrissey
- President, Chief Executive Officer, Founder, Director
- Marshall Fordyce
- Chief Financial Officer
- Sean Grant
- Chief Operating Officer
- David Johnson
- Chief Medical Officer
- Robert Brenner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 54.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.01 |
EPS | $-2.20 |
Book Value | $2.29 |
P/E Ratio | -18.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
